NCT02600468View on ClinicalTrials.gov

Survey on Long-Term Use of ORENCIA® Intravenous Infusion 250mg

CompletedOBSERVATIONAL
Enrollment

671

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Orencia

Sponsors
All Listed Sponsors
collaborator

Ono Pharmaceutical Co. Ltd

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY